Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02316964
What this trial is testing

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Sumithira Vasu 8
Testing effectiveness (Phase 2)UnknownNCT05918198
What this trial is testing

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 52
Testing effectiveness (Phase 2)Study completedNCT01006265
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 464
Early research (Phase 1)Looking for participantsNCT06375044
What this trial is testing

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Looking for participantsNCT06792734
What this trial is testing

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Who this might be right for
Lymphoma, B-Cell
Bantam Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00197951
What this trial is testing

Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism

Who this might be right for
DepressionAngerAnxiety+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 60
Early research (Phase 1)Study completedNCT00039481
What this trial is testing

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
Cardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Early research (Phase 1)Ended earlyNCT04855136
What this trial is testing

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 21
Very early researchUnknownNCT06277011
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
Anhui Provincial Hospital 18
Early research (Phase 1)Active Not RecruitingNCT02159495
What this trial is testing

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more
City of Hope Medical Center 31
Large-scale testing (Phase 3)Looking for participantsNCT07409428
What this trial is testing

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed 240
Testing effectiveness (Phase 2)Ended earlyNCT00479167
What this trial is testing

A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Rush University Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT03697629
What this trial is testing

An Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Canadian Myeloma Research Group 40
Testing effectiveness (Phase 2)Study completedNCT00373295
What this trial is testing

Effect of Baclofen on Marijuana Withdrawal and Relapse

Who this might be right for
Marijuana Dependence
New York State Psychiatric Institute 13
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)UnknownNCT05875428
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)Looking for participantsNCT05868395
What this trial is testing

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle-cell Lymphoma
Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT00003957
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 3
Next Page